ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,37
-0,26%
Bitcoin
61 380,00
0,96%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Novelion Therapeutics Inc (NVLN)

  7. Novelion Therapeutics Inc (NVLN) Actualités

NVLN

Novelion Therapeutics (NVLN)

Novelion Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVLN
DateHeureSourceTitreSymboleSociété
30/03/202022h30Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:NVLNNovelion Therapeutics Inc
13/02/202022h52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
21/01/202023h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
15/01/202023h26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLNNovelion Therapeutics Inc
17/12/201919h38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NVLNNovelion Therapeutics Inc
12/12/201922h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
15/11/201922h33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:NVLNNovelion Therapeutics Inc
08/10/201914h10GlobeNewswire Inc.Novelion Therapeutics Announces Nasdaq DelistingNASDAQ:NVLNNovelion Therapeutics Inc
08/10/201914h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
04/10/201900h21GlobeNewswire Inc.Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matter...NASDAQ:NVLNNovelion Therapeutics Inc
03/10/201923h18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVLNNovelion Therapeutics Inc
27/09/201923h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVLNNovelion Therapeutics Inc
25/09/201914h25GlobeNewswire Inc.Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and OfficersNASDAQ:NVLNNovelion Therapeutics Inc
20/09/201923h23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVLNNovelion Therapeutics Inc
11/09/201923h50GlobeNewswire Inc.Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Ann...NASDAQ:NVLNNovelion Therapeutics Inc
30/08/201914h02GlobeNewswire Inc.Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy CaseNASDAQ:NVLNNovelion Therapeutics Inc
23/08/201923h10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVLNNovelion Therapeutics Inc
21/08/201923h09GlobeNewswire Inc.Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from NasdaqNASDAQ:NVLNNovelion Therapeutics Inc
12/08/201922h34GlobeNewswire Inc.Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019NASDAQ:NVLNNovelion Therapeutics Inc
17/07/201900h43GlobeNewswire Inc.Novelion Therapeutics Announces Dismissal of Whitefort Capital PetitionNASDAQ:NVLNNovelion Therapeutics Inc
05/07/201914h30GlobeNewswire Inc.Novelion Therapeutics Receives Delisting NotificationsNASDAQ:NVLNNovelion Therapeutics Inc
24/06/201914h30GlobeNewswire Inc.Novelion Therapeutics Responds to Whitefort Capital PetitionNASDAQ:NVLNNovelion Therapeutics Inc
21/05/201904h53GlobeNewswire Inc.Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which...NASDAQ:NVLNNovelion Therapeutics Inc
07/05/201922h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVLNNovelion Therapeutics Inc
07/05/201922h01GlobeNewswire Inc.Novelion Therapeutics Reports First Quarter 2019 Financial ResultsNASDAQ:NVLNNovelion Therapeutics Inc
26/04/201915h01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVLNNovelion Therapeutics Inc
31/03/201908h00GlobeNewswire Inc.Novelion Therapeutics Observes World Lipodystrophy DayNASDAQ:NVLNNovelion Therapeutics Inc
29/03/201919h29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVLNNovelion Therapeutics Inc
15/03/201921h06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVLNNovelion Therapeutics Inc
14/03/201922h12GlobeNewswire Inc.Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:NVLNNovelion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NVLN

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
EU
PX1
CAC 40
EU
HO
Thales
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
EU
MC
Lvmh Moet Hennessy Louis...
FTSE
UKX
FTSE 100
EU
BN
Danone
EU
VK
Vallourec
EU
SGO
Cie de SaintGobain
COIN
BTCUSD
Bitcoin
EU
RI
Pernod Ricard
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés